Pengaruh Kortikosteroid Intranasal (Fluticasone Furoate) Terhadap Ekspresi Matriks Metalloproteinase-9 Pada Polip Hidung Di RSUPH Adam Malik Medan
41
DAFTAR PUSTAKA
Amalinei C, Caruntu ID, Balan RA. 2007. Biology of metalloproteinases.
Romanian Journal of Morphology and Embryology 488 (4) : 323324.
Amalinei C et al. 2010. Matrix Metalloproteinases involvement in patologic
conditions. Romanian Journal of Morphology and Embryology 51 (2)
: 215-218.
Anolik A. 2010. Fluticasone furoate nasal spray : Profile of an enhancedaffinity corticosteroid in treatment of seasonal allergic rhinitis. Journal
of asthma and allergy 3: 87-99.
Aouad, R K; Chiu, A G. 2011. “State of the art treatment of nasal
polyposis.”
American journal of rhinlogy & allergy 25, 291-298.
Assanasen, P & Naclerio, RM. 2001. Medical and Nasal surgical
management of nasal polyps in Current opinion in Otolaryngology
and
Head and Neck Surgery. Lippincott William and Wilkins Inc,
p. 27-36.
Bachert, C. 2011. “Evidence- based management of nasal polyposis by
intranasal corticosteroid: from the cause to the clinic.” Int arch allergy
immunol, 155:309-321.
Bachert, C; Watelet, JB; Gevaert, P; Cauwenberge, PV. 2005.
”Pharmacological Management of Nasal Polyposis.” Journal of Drugs
evaluation 66 (1): 1537-1552.
Badia, L; Lund, V. 2001. “Topical corticosteroid in nasal polyposis.”
Review article, drugs ; 61(5) 573-578.
Bugdayci, G; Kaymakci, M; Bukan, N. 2008. “Matrix metalloproteinase-9
(MMP-9) in
allergic nasal polyps.” Acta histochemica 112 : 92-95.
Burgel PR, Cardell LO, Ueki IF. 2004. “Intranasal steroids decrease
eosinophils but not mucous expression in nasal polyps.” Eur Resp
J;24:594–600.
41
Universitas Sumatera Utara
42
Callejas, F B et al. 2014. “Corticosteroid treatment regulates mucosal
remodeling in chronic rhinosinusitis with nasal polyps.” Laryngoscope
25147.
Cao & Zucker. 2007. Biology and Chemistry of matrix metalloproteinases
(MMPs).
Chen, Y S; Langhammer, T; Westhofen, M; Lorenzen, J. 2007.
“Relationship between matrix metalloproteinases MMP-2, MMP-9,
tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal
polyps.” Allergy volume 62, issue 1, p.66-72.
Chi, A H; Annette. 2005. “ Nasal polyposis: an immunohistochemical study
of cell cycle regulator proteins in epithelial proliferation.” A thesis
submitted for the degree of master of science.
Cincik, H et al. 2013.” Evaluation of MMP-9 and TIMP-1 levels of the
patients with nasal polyposis after corticosteroid therapies.” Indian J
Otolaryngol Head Neck Surg, 65: s445-s449.
Cohen, S; Ben Efraim, A N; Levi-Schaffer, F; Eliashar, R. 2011. “The
Effect of hypoxia and cycloxygenase inhibitors on nasal polyp
derived fibroblasts.” American journal of otolaryngology-Head and
Neck Medicine and Surgery 32. 564-573
Dewi, F. 2011. Profil Polip Nasi di RSUP H. Adam Malik Medan Tahun
2010. Tesis Spesialis Ilmu Kesehatan Telinga, Hidung, Tenggorok,
Bedah Kepala dan Leher. FK USU
Djupesland, P G; Vlckova, I; Hewson G. 2010. “Impact of baseline nasal
polyp size and previous surgery on efficacy of fluticasone delivered
with a novel device: A subgroup analysis.” American journal rhinol,
24.3516.
Guerra, G; Testa, D; Marcuccio, G; D´Errico, G; Cianchetta, M R; Cinelli,
M; Russo, A; Montagnani, S. 2012. “TIMPs and MMPs expression in
nasal polyps.” Italian journal of anatomy and embryology, vol 117, n.
2: 87.
Hoshino, M: Takahashi M, Takai Y, Sim J, Aoike N. Inhaled corticosteroids
decrease subepithelial collagen deposition by modulation of the
Universitas Sumatera Utara
43
balance between matrix metalloproteinase-9 and tissue inhibitor of
metalloproteinase-1 expression in asthma. J Allergy Clin Immunol.
1999;104:356–363. doi: 10.1016/S0091-6749(99)70379-9.
Hwang, PH; Abdalkhani, A. 2009. Embryology, Anatomy and Physiology
of
the
Nose
and
Paranasal
Sinuses
in:
Ballenger‟s
Otorhinolaryngology and Head and Neck Surgery. BC Decker Inc,
Ontario, 17th ed, vol 4, p. 455-463
Irfan, M & Shamim, AK 2009,‟Routine Histological Examination for Nasal
Polyp Specimens: Is it Necessary ?‟,Med J Malaysia,vol.1, hal. 5960.
Joe SA, Thambi R & Huang J 2008,‟ A systematic review of the use of
intranasal steroids in the treatment of chronic rinosinusitis,”
Otolaryngol Head Neck Surg 139:340-347
Kahveci, O K; Derekoy, F S; Yilmaz, M D; Serteser, M; Altuntas, A. 2008.
The role of MMP-9 and TIMP-1 in nasal polyp formation. Swiss med
wkly;138 (45-46) : 684-688
Kostamoa K, Toskalab E, Tervahartiala T, Sorsa T. Role of matrix
metalloproteinases in chronic rhinosinusitis. Curr Opin Allergy Clin
Immunol. 2008;8:21–27. doi: 10.1097/ACI.
Kuzminski, A; Przybyszewski, M; Graczyk, M; Bartuzi, Z. 2012. ”The role
of extracellular matrix metalloproteinases and their inhibitors in
allergic diseases.” Postep derm alergol,XXIX,5:384-389.
Lechapt-Zalcman E, Coste A, d‟Ortho MP, et al. Increased expression of
matrix metalloproteinase-9 in nasal polyps. J Pathol. 2001;193:233–
241.
Lee, Y M; Kim, S S; Kim, H A; Suh, Y J; Lee, S K; Nahm, D H; Park, H S.
2003. “ Eosinophil inflammation of nasal polyp tissue: Relationships
with matrix metalloproteinases, tissue inhibitor of metalloproteinase1, and transforming growth factor-β1.” J korean med science; 18:97102.
Universitas Sumatera Utara
44
Mangunkusumo, E dan Wardani, RS. 2007. Polip Hidung dalam: Buku
Ajar Ilmu Kesehatan Telinga, Hidung Tenggorok, Kepala dan Leher.
Balai Penerbit FKUI, Jakarta, edisi keenam, h. 123-5.
Munir, D 2008,„Histopathology Types of Polyposis in Adam Malik Hospital‟,
Majalah Kedokteran Nusantara, vol.1, hal. 1-3.
Mygind, N; Lund, V J. 2008. Nasal polyposis in: Scott-Brown´s
Otorhinolaryngology, Head and Neck Surgery. Hodder Arnold, 7th ed,
vol 2, p. 1549-1557
Pawankar R, Watanabe S, Nonaka M, Ozu C, Aida M, Yagi T. Differential
expression of matrix metalloproteinase 2 and 9 in the allergic nasal
mucosa and nasal polyps. J Allergy Clin Immunol. 2004;113:1229.
doi: 10.1016/j.jaci.2004.01.701.
Pearlman, A N; Chandra, R K; Conley, D B; Kern, R C. 2010. Epidemiologi
of nasal polyps in: Nasal polyposis. Springer- Verlag Berlin.
PERHATI-KL. 2007. Algoritma Penatalaksanaan Polip Hidung dan Sinus
Paranasal (Dewasa) dalam: Guideline penyakit THT-KL di Indonesia.
Product monograph avamys ® fluticasone furoate nasal spray 27.5
mcg/metered spray Corticosteroid for nasal use. 2015
Ryan, M W. 2014. Chronic Rhinosinusitis with nasal polyposis in: Bailey´s
Head and Neck Surgery. Lippincott Williams & Wilkins, 5th ed, part 1,
p. 525-547.
Sauter, A; Stern- Straeter, J; Sodha, S; Hormann, K; Naim, R. 2008.
“Regulation of matrix metalloproteinases (MMP)-2/-9 expression in
eosinophilic chronic rhinosinusitis- cell culture by interleukin-5 and 13.” In vivo 22:415-422.
Schlosser, R J; Woodworth, B A. 2009. Chronic Rhinosinusitis and
Polyposis in: Ballenger´s Otorhinolaryngology and Head and Neck
Surgery. BC Decker Inc, Ontario, 17th ed, vol 4, p. 573-582
Sembiring, E S. 2014. “Perbandingan efek terapi fluticasone furoate
semprot hidung dan metil prednisolon oral pada polip hidung dinilai
dari perubahan jumlah sel radang dan stadium polip hidung.”
repository.usu.ac.id/xmlui/handle/123456789/42402
Universitas Sumatera Utara
45
Soetjipto, D; Mangunkusumo, E; Wardani, RS. 2007. Hidung dalam: Buku
Ajar Ilmu Kesehatan Telinga, Hidung, Tenggorok, Kepala dan Leher.
Balai Penerbit FKUI, Jakarta, edisi keenam, h. 118-22.
Storms, W; Yawn, B; Fromer, L. 2007. Therapeutic options for reducing
sleep impairment in allergic rhinitis, rhinosinusitis, and nasal
polyposis in: Current medical research and opinions, vol 23, no.9, p.
2135-46.
S, De; Fenton, J E; Jones, A S. 2005. “ Matrix m etalloproteinases and
their inhibitors in non- neoplastic otorhinolaryngological disease.” The
journal of laryngology and otology 119.6: 436-42.
Takeuchi, K; Majima, Y. 2005. “Remodeling in chronic sinusitis and nasal
polyps.” Allergology International, 54:39-4.
Topal, O; Erbek, SS; Kiyici, H; Cakmak O. 2008. Expression of
metalloproteinases MMP-9 in antrochoanal polyps. American Journal
of Rhinology 22 : 339-342
Wang, L F; Chien, C Y; Chiang, F Y; Chai, C Y; Tai, C F. 2012.
“Corelationship between matrix metalloproteinase 2 and 9 expression
and severity of chronic rhinosinusitis with nasal polyposis.” American
journal of rhinology & allergy 26, e1-e4.
Wang, C; Lou, H; Wang, X; Wang, Y; Fan, E; Li, Y; Wang, H; Bachert, C;
Zhang, L. 2015. “Effect of budesonide transnasal nebulization in
patients with eosinophilic chronic rhinosinusitis with nasal polyps”
Universitas Sumatera Utara
DAFTAR PUSTAKA
Amalinei C, Caruntu ID, Balan RA. 2007. Biology of metalloproteinases.
Romanian Journal of Morphology and Embryology 488 (4) : 323324.
Amalinei C et al. 2010. Matrix Metalloproteinases involvement in patologic
conditions. Romanian Journal of Morphology and Embryology 51 (2)
: 215-218.
Anolik A. 2010. Fluticasone furoate nasal spray : Profile of an enhancedaffinity corticosteroid in treatment of seasonal allergic rhinitis. Journal
of asthma and allergy 3: 87-99.
Aouad, R K; Chiu, A G. 2011. “State of the art treatment of nasal
polyposis.”
American journal of rhinlogy & allergy 25, 291-298.
Assanasen, P & Naclerio, RM. 2001. Medical and Nasal surgical
management of nasal polyps in Current opinion in Otolaryngology
and
Head and Neck Surgery. Lippincott William and Wilkins Inc,
p. 27-36.
Bachert, C. 2011. “Evidence- based management of nasal polyposis by
intranasal corticosteroid: from the cause to the clinic.” Int arch allergy
immunol, 155:309-321.
Bachert, C; Watelet, JB; Gevaert, P; Cauwenberge, PV. 2005.
”Pharmacological Management of Nasal Polyposis.” Journal of Drugs
evaluation 66 (1): 1537-1552.
Badia, L; Lund, V. 2001. “Topical corticosteroid in nasal polyposis.”
Review article, drugs ; 61(5) 573-578.
Bugdayci, G; Kaymakci, M; Bukan, N. 2008. “Matrix metalloproteinase-9
(MMP-9) in
allergic nasal polyps.” Acta histochemica 112 : 92-95.
Burgel PR, Cardell LO, Ueki IF. 2004. “Intranasal steroids decrease
eosinophils but not mucous expression in nasal polyps.” Eur Resp
J;24:594–600.
41
Universitas Sumatera Utara
42
Callejas, F B et al. 2014. “Corticosteroid treatment regulates mucosal
remodeling in chronic rhinosinusitis with nasal polyps.” Laryngoscope
25147.
Cao & Zucker. 2007. Biology and Chemistry of matrix metalloproteinases
(MMPs).
Chen, Y S; Langhammer, T; Westhofen, M; Lorenzen, J. 2007.
“Relationship between matrix metalloproteinases MMP-2, MMP-9,
tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal
polyps.” Allergy volume 62, issue 1, p.66-72.
Chi, A H; Annette. 2005. “ Nasal polyposis: an immunohistochemical study
of cell cycle regulator proteins in epithelial proliferation.” A thesis
submitted for the degree of master of science.
Cincik, H et al. 2013.” Evaluation of MMP-9 and TIMP-1 levels of the
patients with nasal polyposis after corticosteroid therapies.” Indian J
Otolaryngol Head Neck Surg, 65: s445-s449.
Cohen, S; Ben Efraim, A N; Levi-Schaffer, F; Eliashar, R. 2011. “The
Effect of hypoxia and cycloxygenase inhibitors on nasal polyp
derived fibroblasts.” American journal of otolaryngology-Head and
Neck Medicine and Surgery 32. 564-573
Dewi, F. 2011. Profil Polip Nasi di RSUP H. Adam Malik Medan Tahun
2010. Tesis Spesialis Ilmu Kesehatan Telinga, Hidung, Tenggorok,
Bedah Kepala dan Leher. FK USU
Djupesland, P G; Vlckova, I; Hewson G. 2010. “Impact of baseline nasal
polyp size and previous surgery on efficacy of fluticasone delivered
with a novel device: A subgroup analysis.” American journal rhinol,
24.3516.
Guerra, G; Testa, D; Marcuccio, G; D´Errico, G; Cianchetta, M R; Cinelli,
M; Russo, A; Montagnani, S. 2012. “TIMPs and MMPs expression in
nasal polyps.” Italian journal of anatomy and embryology, vol 117, n.
2: 87.
Hoshino, M: Takahashi M, Takai Y, Sim J, Aoike N. Inhaled corticosteroids
decrease subepithelial collagen deposition by modulation of the
Universitas Sumatera Utara
43
balance between matrix metalloproteinase-9 and tissue inhibitor of
metalloproteinase-1 expression in asthma. J Allergy Clin Immunol.
1999;104:356–363. doi: 10.1016/S0091-6749(99)70379-9.
Hwang, PH; Abdalkhani, A. 2009. Embryology, Anatomy and Physiology
of
the
Nose
and
Paranasal
Sinuses
in:
Ballenger‟s
Otorhinolaryngology and Head and Neck Surgery. BC Decker Inc,
Ontario, 17th ed, vol 4, p. 455-463
Irfan, M & Shamim, AK 2009,‟Routine Histological Examination for Nasal
Polyp Specimens: Is it Necessary ?‟,Med J Malaysia,vol.1, hal. 5960.
Joe SA, Thambi R & Huang J 2008,‟ A systematic review of the use of
intranasal steroids in the treatment of chronic rinosinusitis,”
Otolaryngol Head Neck Surg 139:340-347
Kahveci, O K; Derekoy, F S; Yilmaz, M D; Serteser, M; Altuntas, A. 2008.
The role of MMP-9 and TIMP-1 in nasal polyp formation. Swiss med
wkly;138 (45-46) : 684-688
Kostamoa K, Toskalab E, Tervahartiala T, Sorsa T. Role of matrix
metalloproteinases in chronic rhinosinusitis. Curr Opin Allergy Clin
Immunol. 2008;8:21–27. doi: 10.1097/ACI.
Kuzminski, A; Przybyszewski, M; Graczyk, M; Bartuzi, Z. 2012. ”The role
of extracellular matrix metalloproteinases and their inhibitors in
allergic diseases.” Postep derm alergol,XXIX,5:384-389.
Lechapt-Zalcman E, Coste A, d‟Ortho MP, et al. Increased expression of
matrix metalloproteinase-9 in nasal polyps. J Pathol. 2001;193:233–
241.
Lee, Y M; Kim, S S; Kim, H A; Suh, Y J; Lee, S K; Nahm, D H; Park, H S.
2003. “ Eosinophil inflammation of nasal polyp tissue: Relationships
with matrix metalloproteinases, tissue inhibitor of metalloproteinase1, and transforming growth factor-β1.” J korean med science; 18:97102.
Universitas Sumatera Utara
44
Mangunkusumo, E dan Wardani, RS. 2007. Polip Hidung dalam: Buku
Ajar Ilmu Kesehatan Telinga, Hidung Tenggorok, Kepala dan Leher.
Balai Penerbit FKUI, Jakarta, edisi keenam, h. 123-5.
Munir, D 2008,„Histopathology Types of Polyposis in Adam Malik Hospital‟,
Majalah Kedokteran Nusantara, vol.1, hal. 1-3.
Mygind, N; Lund, V J. 2008. Nasal polyposis in: Scott-Brown´s
Otorhinolaryngology, Head and Neck Surgery. Hodder Arnold, 7th ed,
vol 2, p. 1549-1557
Pawankar R, Watanabe S, Nonaka M, Ozu C, Aida M, Yagi T. Differential
expression of matrix metalloproteinase 2 and 9 in the allergic nasal
mucosa and nasal polyps. J Allergy Clin Immunol. 2004;113:1229.
doi: 10.1016/j.jaci.2004.01.701.
Pearlman, A N; Chandra, R K; Conley, D B; Kern, R C. 2010. Epidemiologi
of nasal polyps in: Nasal polyposis. Springer- Verlag Berlin.
PERHATI-KL. 2007. Algoritma Penatalaksanaan Polip Hidung dan Sinus
Paranasal (Dewasa) dalam: Guideline penyakit THT-KL di Indonesia.
Product monograph avamys ® fluticasone furoate nasal spray 27.5
mcg/metered spray Corticosteroid for nasal use. 2015
Ryan, M W. 2014. Chronic Rhinosinusitis with nasal polyposis in: Bailey´s
Head and Neck Surgery. Lippincott Williams & Wilkins, 5th ed, part 1,
p. 525-547.
Sauter, A; Stern- Straeter, J; Sodha, S; Hormann, K; Naim, R. 2008.
“Regulation of matrix metalloproteinases (MMP)-2/-9 expression in
eosinophilic chronic rhinosinusitis- cell culture by interleukin-5 and 13.” In vivo 22:415-422.
Schlosser, R J; Woodworth, B A. 2009. Chronic Rhinosinusitis and
Polyposis in: Ballenger´s Otorhinolaryngology and Head and Neck
Surgery. BC Decker Inc, Ontario, 17th ed, vol 4, p. 573-582
Sembiring, E S. 2014. “Perbandingan efek terapi fluticasone furoate
semprot hidung dan metil prednisolon oral pada polip hidung dinilai
dari perubahan jumlah sel radang dan stadium polip hidung.”
repository.usu.ac.id/xmlui/handle/123456789/42402
Universitas Sumatera Utara
45
Soetjipto, D; Mangunkusumo, E; Wardani, RS. 2007. Hidung dalam: Buku
Ajar Ilmu Kesehatan Telinga, Hidung, Tenggorok, Kepala dan Leher.
Balai Penerbit FKUI, Jakarta, edisi keenam, h. 118-22.
Storms, W; Yawn, B; Fromer, L. 2007. Therapeutic options for reducing
sleep impairment in allergic rhinitis, rhinosinusitis, and nasal
polyposis in: Current medical research and opinions, vol 23, no.9, p.
2135-46.
S, De; Fenton, J E; Jones, A S. 2005. “ Matrix m etalloproteinases and
their inhibitors in non- neoplastic otorhinolaryngological disease.” The
journal of laryngology and otology 119.6: 436-42.
Takeuchi, K; Majima, Y. 2005. “Remodeling in chronic sinusitis and nasal
polyps.” Allergology International, 54:39-4.
Topal, O; Erbek, SS; Kiyici, H; Cakmak O. 2008. Expression of
metalloproteinases MMP-9 in antrochoanal polyps. American Journal
of Rhinology 22 : 339-342
Wang, L F; Chien, C Y; Chiang, F Y; Chai, C Y; Tai, C F. 2012.
“Corelationship between matrix metalloproteinase 2 and 9 expression
and severity of chronic rhinosinusitis with nasal polyposis.” American
journal of rhinology & allergy 26, e1-e4.
Wang, C; Lou, H; Wang, X; Wang, Y; Fan, E; Li, Y; Wang, H; Bachert, C;
Zhang, L. 2015. “Effect of budesonide transnasal nebulization in
patients with eosinophilic chronic rhinosinusitis with nasal polyps”
Universitas Sumatera Utara